WEE1 and hepatocellular carcinoma: The 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway is reported to inhibit the EMT in pancreatic cancer (5), hepatocellular carcinoma (HCC) (6), and breast cancer (7).